Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08XES
|
|||
| Drug Name |
PMID27215781-Compound-4
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
F. HOFFMANN-LA ROCHE AG BISSANTZ, Caterina DHURWASULU, Baledi GRETHER, Uwe HAZRA, Anindya HEBEISEN, Paul ROEVER, Stephan ROGERS-EVANS, Mark
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H24F2N4O4
|
|||
| Canonical SMILES |
CC(C1CC1)(C(=O)OC)NC(=O)C2=CN=C(C(=N2)OCC3CC3)N4CC(C4)(F)F
|
|||
| InChI |
1S/C19H24F2N4O4/c1-18(12-5-6-12,17(27)28-2)24-15(26)13-7-22-14(25-9-19(20,21)10-25)16(23-13)29-8-11-3-4-11/h7,11-12H,3-6,8-10H2,1-2H3,(H,24,26)
|
|||
| InChIKey |
ZVGNNTZBRRKTHH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Agonist | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.